INDIAN SCIENTISTS INCH CLOSER TO DEVELOP A NEW BLOOD CANCER DRUG
DR REDDY ’ S LABORATORIES GETS USFDA ’ S EIR TO API PLANT IN TELANGANA
news bytes
INDIAN SCIENTISTS INCH CLOSER TO DEVELOP A NEW BLOOD CANCER DRUG
A group of Indian scientists has a found a new compound that effectively kills leukemic cancer cells . Codenamed 5g , the new drug can kill over 70 percent blood cancer cells in a petri dish in 48 hours at an extremely low concentration . It did not affect healthy blood cells , which signifies that is toxic to cancer cells . “ After treating with 5g cancer cells either entered cell death or reverted back to normal cell cycle ”, say scientists who have tested this new compound .
The drug has been tested in laboratory animals . Daily doses of 5g for two weeks reduced the size of tumor in mice . It was non-toxic and moderately increased the life span of diseased mice . The tumor regression was incomplete , because of which , the scientists suggest that 5g needs combinational compounds to increase its efficiency .
This study was done at the Indian
Institute of Science in Bangalore , University of Mysore in Mysuru , and Institute of Bioinformatics and Applied Biotechnology in Bangalore . It was supported by IISc-Department of Biotechnology partnership .
DR REDDY ’ S LABORATORIES GETS USFDA ’ S EIR TO API PLANT IN TELANGANA
Dr Reddy ’ s Laboratories in its recent filing to the National Stock Exchange ( NSE ) broke the news that company has received an establishment inspection report ( EIR ) from the USFDA on 16th June as the closure of audit for the above-referred facility .
The company has said that the US Food and Drug Administration , which inspected active pharmaceutical ingredients ( API ) unit at Miryalaguda in Telangana in March this year , has given an ‘ establishment inspection report ’.
Earlier on February 21 , the company had informed that the FDA had issued form 483 with
58 BioVoiceNews | July 2017